Navigation Links
Ferring Pharmaceuticals Announces Disco Icon Gloria Gaynor as National Spokesperson for EUFLEXXA(R)
Date:5/13/2010

EUFLEXXA® (1% sodium hyaluronate) is used to relieve knee pain due to osteoarthritis. It is used in people who do not get enough relief from simple pain medications such as acetaminophen or from exercise and physical therapy.

IMPORTANT SAFETY INFORMATION

You should not receive this product if you have had any previous allergic reaction to EUFLEXXA® or hyaluronan products. You should not have an injection into the knee if you have a knee joint infection or if you have skin disease or infection around the injection site.

EUFLEXXA® is only for injection into the knee performed by a qualified doctor. After you receive this injection you may need to avoid activities such as jogging, tennis, heavy lifting, or standing on your feet for a long time (more than one hour). The safety and effectiveness of repeat treatment cycles of EUFLEXXA® have not been established. The safety and effectiveness of EUFLEXXA® have not been shown in people under 18 years of age.

Side effects sometimes seen when EUFLEXXA® is injected into the knee joint were pain, swelling, skin irritation, and tenderness and these were generally mild and did not last long.

About Ferring Pharmaceuticals Inc.

Ferring Pharmaceuticals Inc. is a subsidiary of Ferring Pharmaceuticals, a privately owned, international pharmaceutical company.  Ferring Pharmaceuticals offers a line of products in the U.S. market.  They include: BRAVELLE® (urofollitropin for injection, purified), MENOPUR® (menotropins for injection, USP) and REPRONEX® (menotropins for injection, USP), NOVAREL® (chorionic gonadotropin for injection, USP), ENDOMETRIN® (progesterone) Vaginal Insert, 100 mg, FIRMAGON® (degarelix for injection), PROSED® DS (methena
'/>"/>

SOURCE Ferring Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ferring Acquires LYSTEDA(TM) From Xanodyne Pharmaceuticals, Inc.
2. Ferring Pharmaceuticals and Gene Security Network Partner to Test Advanced Preimplantation Genetic Diagnosis (PGD) Technology
3. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
4. Timm Medical Technologies and Ferring Pharmaceuticals Enter Exclusive Co-Promotion Agreement for Prosed(R) DS
5. Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain
6. Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy
7. deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer
8. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2010 First Quarter Earnings Conference Call on Monday, May 17, 2010 at 9:30 a.m. ET
9. Jazz Pharmaceuticals Announces Public Offering of Common Stock
10. China Yongxin Pharmaceuticals is Selected as one of the Qualified Pharmaceutical Distributors for Jilin Province
11. Epix Pharmaceuticals, Inc. Announces Additional Information Concerning the May 28, 2010 Auction Sale of EP-2104R MRI Imaging Agent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 2015 Research and Markets ( ... "Eurpoean Automatic External Defibrillators (AED) Market by ... Market, Hospitals, Alternate Care Market, Home) - Forecast ... The European automated external defibrillator (AED) market ... 10.9% from 2014 to 2019 ...
(Date:3/31/2015)... , March 31, 2015 The Medical ... featured in the American Medical Group Association,s "High ... AMGA,s "High Performing Health" production is ... facing the nation,s healthcare system in delivering better ... profiled along with other leading organizations in the ...
(Date:3/31/2015)... 31, 2015 Accelerated orthodontic treatment will ... of Orthodontics 2015 Annual Session, May 15-19, as ... lectures on AcceleDent ® . Manufactured by OrthoAccel ... orthodontics, AcceleDent is a FDA-cleared, Class II medical ... much as 50 percent with just 20 minutes ...
Breaking Medicine Technology:Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 2Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 3AMGA's High Performing Health News Program Features The Medical Letter 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 3
... Inc. (ARKRAY) announced today that the GLUCOCARD® Vital and ... (DoD) Uniform Formulary.  The DoD Pharmacy and Therapeutic committee ... 01 Blood Glucose Meters as the first and second ... of service as noted by the Uniform Formulary Beneficiary ...
... Oct. 28, 2011 Pearl Therapeutics Inc. presented ... foundations of the Company,s cosuspension technology which uses ... via pressurized metered dose inhalers (MDIs). Two posters ... Association of Pharmaceutical Scientists annual meeting in Washington ...
Cached Medicine Technology:ARKRAY's GLUCOCARD® Vital and 01 Blood Glucose Meters are now on the Department of Defense Uniform Formulary. 2Pearl Therapeutics Presents New Scientific Evidence Supporting Versatility of Its Novel Cosuspension MDI Platform 2Pearl Therapeutics Presents New Scientific Evidence Supporting Versatility of Its Novel Cosuspension MDI Platform 3
(Date:3/31/2015)... San Francisco, CA (PRWEB) March 31, 2015 ... announces their upcoming events. The schedule for April will ... as follows: , New Student Orientation, 9-11 a.m. April ... be held in Room D at the Pioneer Square ... Tuition & Financial Aid, 12:30-1:30 p.m. April 14, Students ...
(Date:3/31/2015)... Karen A. Daley, Ph.D. will address graduates ... Commencement ceremony on May 9, 2015 and will ... of her eminent career as a nurse, public health ... and senior staff nurse at Brigham and Women’s Hospital ... roles, including President of the American Nurses Association in ...
(Date:3/31/2015)... Simeon Boyd, UC Davis professor of ... five-year grant from the National Institute of Dental and ... scientists from more than 10 centers in the United ... Germany, Hungary, Italy and the United Kingdom, to study ... the skull in infants. , The researchers are members ...
(Date:3/31/2015)... Medical DNA Labs, LLC, An Affiliate ... for Laboratory Accreditation by COLA, a national healthcare accreditation ... apply rigid standards of quality in day-to-day operations, demonstrate ... pass a rigorous on-site laboratory survey. Medical DNA ... of a long-term commitment to provide quality service to ...
(Date:3/31/2015)... Clara, CA (PRWEB) March 31, 2015 ... (IPD), has introduced a wire-bondable silicon ESD diode chip targeted ... of bare-die diode offerings, these Zeners are ideal for protecting ... ESD2117 diode can handle pulses of up to ... level 4 of the IEC 61000-4-2 standard. These diodes ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces April Event Schedule 2Health News:Rivier University to recognize nurse leader, educator and safety advocate at 80th Commencement on May 9th 2Health News:Rivier University to recognize nurse leader, educator and safety advocate at 80th Commencement on May 9th 3Health News:International team of researchers led by UC Davis receives $4 million NIH grant to study skull disorder in infants 2Health News:International team of researchers led by UC Davis receives $4 million NIH grant to study skull disorder in infants 3Health News:Local Medical DNA Labs, LLC. Recognized for Quality Laboratory Services 2Health News:OnChip Introduces Low Voltage Diodes for High-Brightness LED Protection 2
... Pa., Aug. 19 Genesis HealthCare , ... that 16 of its Centers have been recognized as 2009 ... the American Health Care Association and National Center for Assisted ... from across the nation applied for the quality award at ...
... PITTSBURGHA multidisciplinary team led by Carnegie Mellon University ... five-year, $10 million grant from the National Science ... computational tools that will advance science on a ... treatments to designing safer aircraft. The researchers will ...
... liver disease characterized by progressive inflammation and destruction of ... leading to biliary cirrhosis, portal hypertension and liver failure ... common cause of adult cholestatic liver diseases and a ... U.S. adults. At least 70% of PSC cases ...
... , , INDIANAPOLIS and MINNEAPOLIS, ... nation,s leading health benefits provider, and RedBr i ... Earnings(TM) company, today announced the two parties have entered into a ... for WellPoint,s affiliated health plans, large employers and health plan customers. ...
... , , , ... BMRN ) announced today that data from clinical studies of Kuvan(R) ... Annual Meeting of the International Congress of Inborn Errors of Metabolism ... , , "We look forward to a number ...
... , , LANHAM, Md., Aug. ... national immunization awareness campaign, Protecting our Future: The COSHAR ... with new materials, including updated information about autism and vaccines ... available now. , , Through ...
Cached Medicine News:Health News:Sixteen Genesis HealthCare Centers Receive Prestigious Award for Continuous Quality Improvement in Long Term Care 2Health News:Sixteen Genesis HealthCare Centers Receive Prestigious Award for Continuous Quality Improvement in Long Term Care 3Health News:Carnegie Mellon leads NSF initiative to develop modeling tools for disease and complex systems 2Health News:Carnegie Mellon leads NSF initiative to develop modeling tools for disease and complex systems 3Health News:Carnegie Mellon leads NSF initiative to develop modeling tools for disease and complex systems 4Health News:Carnegie Mellon leads NSF initiative to develop modeling tools for disease and complex systems 5Health News:Study finds adverse effects in treatment for primary sclerosing cholangitis 2Health News:WellPoint Collaborates with RedBrick Health to Create Integrated, Behavior-Based Wellness and Incentives Programs 2Health News:WellPoint Collaborates with RedBrick Health to Create Integrated, Behavior-Based Wellness and Incentives Programs 3Health News:WellPoint Collaborates with RedBrick Health to Create Integrated, Behavior-Based Wellness and Incentives Programs 4Health News:Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 2Health News:Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 3Health News:Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 4Health News:Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 5Health News:Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 6Health News:COSHAR Foundation Enhances National Childhood Immunization Awareness Campaign 2
For the quantitative determination of creatine kinase in serum. Kinetic Reaction measured at 340 nm. Linearity: 1500 IU/L at 37C....
For the quantitative determination of total glucose in human serum....
Intended for the quantitative determination of glucose in biological fluids. Reaction: endpoint. Wavelength: 340 nm. Linearity: 800 mg/dL (44.4 mmol/L)....
For the quantitative determination of Glucose in serum. Endpoint Reaction Product measured at 520 nm. Linearity: 500 mg/dl....
Medicine Products: